CD163 and neoplasm: To the best of our knowledge, that could indicate either loss of CD45 during the differentiation of CD68+CD163− cells in tumour tissue or their origin from tissue-resident macrophages, while CD68+CD163+cells, at least partially, demonstrate they origin from blood monocytes.